JIUDIAN PHARMACEUTICAL
30070511.011.01% ( +0.11 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: JIUDIAN PHARMACEUTICAL(300705) the Revenue is 595.24 M (-14.48%);the EBIT is 69.92 M (-53.1%);the EPS is 0.11 (-56%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.60B14.48%
----
----
EBIT
0.07B53.10%
----
----
EPS
0.1156.00%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf